These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 6986410

  • 1. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.
    Weiss J, Beckerdite-Quagliata S, Elsbach P.
    J Clin Invest; 1980 Mar; 65(3):619-28. PubMed ID: 6986410
    [Abstract] [Full Text] [Related]

  • 2. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J, Muello K, Victor M, Elsbach P.
    J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924
    [Abstract] [Full Text] [Related]

  • 3. Killing of gram-negative bacteria by polymorphonuclear leukocytes: role of an O2-independent bactericidal system.
    Weiss J, Victor M, Stendhal O, Elsbach P.
    J Clin Invest; 1982 Apr; 69(4):959-70. PubMed ID: 7042758
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.
    Qi SY, Li Y, O'Connor CD.
    Biochem J; 1994 Mar 15; 298 Pt 3(Pt 3):711-8. PubMed ID: 8141787
    [Abstract] [Full Text] [Related]

  • 8. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C, Chen S, Sidorczyk Z, Elsbach P, Weiss J.
    Infect Immun; 1994 Jan 15; 62(1):259-65. PubMed ID: 8262637
    [Abstract] [Full Text] [Related]

  • 9. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE, Weiss J, Doerfler ME, Elsbach P.
    J Exp Med; 1991 Sep 01; 174(3):649-55. PubMed ID: 1875165
    [Abstract] [Full Text] [Related]

  • 10. Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship.
    Elsbach P, Weiss J, Franson RC, Beckerdite-Quagliata S, Schneider A, Harris L.
    J Biol Chem; 1979 Nov 10; 254(21):11000-9. PubMed ID: 500619
    [Abstract] [Full Text] [Related]

  • 11. The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics.
    Snyder DS, McIntosh TJ.
    Biochemistry; 2000 Sep 26; 39(38):11777-87. PubMed ID: 10995246
    [Abstract] [Full Text] [Related]

  • 12. Bactericidal activity of specific and azurophil granules from human neutrophils: studies with outer-membrane mutants of Salmonella typhimurium LT-2.
    Rest RF, Cooney MH, Spitznagel JK.
    Infect Immun; 1978 Jan 26; 19(1):131-7. PubMed ID: 24000
    [Abstract] [Full Text] [Related]

  • 13. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O, Ooi CE, Elsbach P, Doerfler ME, Lehrer RI, Weiss J.
    J Immunol; 1995 May 15; 154(10):5403-10. PubMed ID: 7730641
    [Abstract] [Full Text] [Related]

  • 14. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli.
    Mannion BA, Weiss J, Elsbach P.
    J Clin Invest; 1990 Aug 15; 86(2):631-41. PubMed ID: 2200807
    [Abstract] [Full Text] [Related]

  • 15. Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.
    O'Hara AM, Moran AP, Würzner R, Orren A.
    Immunology; 2001 Mar 15; 102(3):365-72. PubMed ID: 11298837
    [Abstract] [Full Text] [Related]

  • 16. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides.
    Munford RS, Hall CL, Lipton JM, Dietschy JM.
    J Clin Invest; 1982 Oct 15; 70(4):877-88. PubMed ID: 6749904
    [Abstract] [Full Text] [Related]

  • 17. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL, Duncan RL, Morrison DC.
    J Immunol; 1986 Aug 15; 137(4):1329-35. PubMed ID: 3525676
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interactions between magainin 2 and Salmonella typhimurium outer membranes: effect of lipopolysaccharide structure.
    Rana FR, Macias EA, Sultany CM, Modzrakowski MC, Blazyk J.
    Biochemistry; 1991 Jun 18; 30(24):5858-66. PubMed ID: 2043628
    [Abstract] [Full Text] [Related]

  • 20. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.
    Appelmelk BJ, Maaskant JJ, Verweij-van Vught AM, van der Meer NM, Thijs BG, MacLaren DM.
    J Gen Microbiol; 1993 Nov 18; 139(11):2641-7. PubMed ID: 7506295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.